Thus, BMAL1 mostly has a protective role in CNS organic lesions and neurological disease by reducing inflammation and oxidative stress, but in white matter damage, which affects OL, BMAL1 deficiency also has a protective effect (Table A1); hence, future therapeutic strategies may depend on target cells. This evidence concerns the gene BMAL1 and nervous system disorder.